+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceuticals - Market Analysis, Trends, and Forecasts

  • ID: 3301135
  • Report
  • October 2019
  • Region: Global, Global
  • 277 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Amgen
  • Biogen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE
The Biopharmaceuticals market worldwide is projected to grow by US$296.9 Billion, driven by a compounded growth of 13.6%. Monoclonal Antibody, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$173.7 Billion by the year 2025, Monoclonal Antibody will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$11.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$9.7 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Monoclonal Antibody will reach a market size of US$8.9 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.4% over the next couple of years and add approximately US$71.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott Diagnostics, Inc. - Core Laboratory
  • Amgen, Inc.
  • Biogen, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Sanofi
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Biogen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Biopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Biopharmaceuticals Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Biopharmaceuticals Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Biopharmaceuticals Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Monoclonal Antibody (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Monoclonal Antibody (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Monoclonal Antibody (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Interferon (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Interferon (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Interferon (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Insulin (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Insulin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Insulin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Growth & Coagulation Factor (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Growth & Coagulation Factor (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Growth & Coagulation Factor (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Erythropoietin (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Erythropoietin (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Erythropoietin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Vaccine (Product) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Vaccine (Product) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Vaccine (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Hormone (Product) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Hormone (Product) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Hormone (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Other Products (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Other Products (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Other Products (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Oncology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 29: Oncology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017

TABLE 30: Oncology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 31: Blood Disorder (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025

TABLE 32: Blood Disorder (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 33: Blood Disorder (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Metabolic Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 35: Metabolic Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017

TABLE 36: Metabolic Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: Infectious Disease (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 38: Infectious Disease (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017

TABLE 39: Infectious Disease (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

TABLE 40: Cardiovascular Disease (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 41: Cardiovascular Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 42: Cardiovascular Disease (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 43: Neurological Disease (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 44: Neurological Disease (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017

TABLE 45: Neurological Disease (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 46: Immunology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 47: Immunology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017

TABLE 48: Immunology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 49: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025

TABLE 50: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 51: Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Biopharmaceuticals Market Share (in %) by Company: 2019 & 2025

TABLE 52: United States Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 53: Biopharmaceuticals Market in the United States by Product: A Historic Review in US$ Million for 2009-2017

TABLE 54: United States Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 55: United States Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 56: Biopharmaceuticals Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017

TABLE 57: Biopharmaceuticals Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

CANADA

TABLE 58: Canadian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 59: Canadian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017

TABLE 60: Biopharmaceuticals Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 61: Canadian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 62: Biopharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 63: Canadian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

JAPAN

TABLE 64: Japanese Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 65: Biopharmaceuticals Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 66: Japanese Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 67: Japanese Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 68: Japanese Biopharmaceuticals Market in US$ Million by Application: 2009-2017

TABLE 69: Biopharmaceuticals Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

CHINA

TABLE 70: Chinese Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 71: Biopharmaceuticals Historic Market Analysis in China in US$ Million by Product: 2009-2017

TABLE 72: Chinese Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 73: Chinese Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 74: Biopharmaceuticals Market Review in China in US$ Million by Application: 2009-2017

TABLE 75: Chinese Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025

FRANCE

TABLE 76: Biopharmaceuticals Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: French Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 78: French Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 79: Biopharmaceuticals Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 80: French Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017

TABLE 81: French Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Biopharmaceuticals Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 82: European Biopharmaceuticals Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 83: Biopharmaceuticals Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 84: European Biopharmaceuticals Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 85: European Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 86: Biopharmaceuticals Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 87: European Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 88: European Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 89: Biopharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 90: European Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

GERMANY

TABLE 91: Biopharmaceuticals Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 92: German Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 93: German Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 94: Biopharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 95: German Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 96: Biopharmaceuticals Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025

ITALY

TABLE 97: Italian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 98: Biopharmaceuticals Historic Market Analysis in Italy in US$ Million by Product: 2009-2017

TABLE 99: Italian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 100: Italian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 101: Biopharmaceuticals Market Review in Italy in US$ Million by Application: 2009-2017

TABLE 102: Italian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 103: United Kingdom Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 104: Biopharmaceuticals Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 105: United Kingdom Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 106: United Kingdom Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 107: United Kingdom Biopharmaceuticals Market in US$ Million by Application: 2009-2017

TABLE 108: Biopharmaceuticals Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

SPAIN

TABLE 109: Spanish Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 110: Spanish Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017

TABLE 111: Biopharmaceuticals Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 112: Spanish Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 113: Biopharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 114: Spanish Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

RUSSIA

TABLE 115: Russian Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 116: Biopharmaceuticals Market in Russia by Product: A Historic Review in US$ Million for 2009-2017

TABLE 117: Russian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 118: Russian Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 119: Biopharmaceuticals Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017

TABLE 120: Biopharmaceuticals Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 121: Rest of Europe Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 122: Biopharmaceuticals Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 123: Rest of Europe Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 124: Rest of Europe Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 125: Biopharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 126: Rest of Europe Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 127: Asia-Pacific Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 128: Biopharmaceuticals Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 129: Asia-Pacific Biopharmaceuticals Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 130: Biopharmaceuticals Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 131: Asia-Pacific Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 132: Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 133: Biopharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 134: Asia-Pacific Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017

TABLE 135: Asia-Pacific Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

AUSTRALIA

TABLE 136: Biopharmaceuticals Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 137: Australian Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 138: Australian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 139: Biopharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 140: Australian Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 141: Biopharmaceuticals Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025

INDIA

TABLE 142: Indian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 143: Indian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017

TABLE 144: Biopharmaceuticals Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 145: Indian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 146: Biopharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 147: Indian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

SOUTH KOREA

TABLE 148: Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 149: South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 150: Biopharmaceuticals Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025

TABLE 151: Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025

TABLE 152: South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017

TABLE 153: Biopharmaceuticals Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 154: Rest of Asia-Pacific Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 155: Biopharmaceuticals Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 156: Rest of Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 157: Rest of Asia-Pacific Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 158: Rest of Asia-Pacific Biopharmaceuticals Market in US$ Million by Application: 2009-2017

TABLE 159: Biopharmaceuticals Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 160: Latin American Biopharmaceuticals Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 161: Biopharmaceuticals Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 162: Latin American Biopharmaceuticals Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 163: Latin American Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 164: Biopharmaceuticals Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017

TABLE 165: Latin American Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 166: Latin American Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 167: Biopharmaceuticals Market Review in Latin America in US$ Million by Application: 2009-2017

TABLE 168: Latin American Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025

ARGENTINA

TABLE 169: Argentinean Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 170: Biopharmaceuticals Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 171: Argentinean Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 172: Argentinean Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 173: Biopharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 174: Argentinean Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

BRAZIL

TABLE 175: Biopharmaceuticals Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 176: Brazilian Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 177: Brazilian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 178: Biopharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025

TABLE 179: Brazilian Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017

TABLE 180: Brazilian Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

MEXICO

TABLE 181: Biopharmaceuticals Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 182: Mexican Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 183: Mexican Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 184: Biopharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 185: Mexican Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 186: Biopharmaceuticals Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 187: Rest of Latin America Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 188: Biopharmaceuticals Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017

TABLE 189: Rest of Latin America Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 190: Rest of Latin America Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 191: Biopharmaceuticals Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017

TABLE 192: Biopharmaceuticals Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 193: The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 194: Biopharmaceuticals Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 195: The Middle East Biopharmaceuticals Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 196: The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 197: The Middle East Biopharmaceuticals Historic Market by Product in US$ Million: 2009-2017

TABLE 198: Biopharmaceuticals Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 199: The Middle East Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 200: Biopharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 201: The Middle East Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

IRAN

TABLE 202: Iranian Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 203: Biopharmaceuticals Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 204: Iranian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 205: Iranian Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 206: Iranian Biopharmaceuticals Market in US$ Million by Application: 2009-2017

TABLE 207: Biopharmaceuticals Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025

ISRAEL

TABLE 208: Israeli Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 209: Biopharmaceuticals Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 210: Israeli Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 211: Israeli Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 212: Biopharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 213: Israeli Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 214: Saudi Arabian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 215: Biopharmaceuticals Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017

TABLE 216: Saudi Arabian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 217: Saudi Arabian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025

TABLE 218: Biopharmaceuticals Market Review in Saudi Arabia in US$ Million by Application: 2009-2017

TABLE 219: Saudi Arabian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED ARAB EMIRATES

TABLE 220: Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 221: United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 222: Biopharmaceuticals Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025

TABLE 223: Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025

TABLE 224: United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017

TABLE 225: Biopharmaceuticals Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 226: Biopharmaceuticals Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 227: Rest of Middle East Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 228: Rest of Middle East Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 229: Biopharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 230: Rest of Middle East Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 231: Biopharmaceuticals Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025

AFRICA

TABLE 232: African Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 233: Biopharmaceuticals Market in Africa by Product: A Historic Review in US$ Million for 2009-2017

TABLE 234: African Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 235: African Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 236: Biopharmaceuticals Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017

TABLE 237: Biopharmaceuticals Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT DIAGNOSTICS, INC. - CORE LABORATORY

AMGEN

BIOGEN

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

JOHNSON & JOHNSON

MERCK & CO., INC.

NOVO NORDISK A/S

PFIZER, INC

SANOFI

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Diagnostics, Inc. - Core Laboratory
  • Amgen
  • Biogen
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer, Inc
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll